During pregnancy the mouse uterine epithelial synthesis of the mononuclear phagocyte growth factor designated colony-stimulating factor 1 (CSF-1) is regulated by female sex steroids. To study the role of CSF-1 in the pregnant female reproductive tract, the temporal expression and cellular sites of synthesis of CSF-1 and CSF-1 receptor (CSF-1R) mRNA were determined. CSF-1 mRNA, predominantly the 2.3-kilobase (kb) form, was first detected by in situ hybridization in uterine epithelium prior to implantation on day 3 and subsequently increased, reaching a peak at days 14-15.
The growth and differentiation of many cell types are regulated by specific polypeptide growth factors (1) . The rapid proliferation of both uterine and fetal cells during implantation and in the formation of the placenta and extra-embryonic membranes suggests that growth factors play a role in these processes. During gestation, the uterus and placenta produce a variety of growth factors (2) . Both trophoblasts and decidual cells express receptors for some of these growth factors, raising the possibility of autocrine, paracrine or local, nonsystemic stimulation (2, 3) .
We recently demonstrated that a growth factor for mononuclear phagocytes, colony-stimulating factor 1 (CSF-1; ref. 4) , is synthesized by uterine epithelium during pregnancy in the mouse (5, 6) . Although macrophages accumulate to high numbers in the pregnant uterus (7) , the detection of the CSF-1 receptor (CSF-1R, the c-fms protooncogene product; ref. 8) mRNA in human and mouse placenta (9) (10) (11) and the stimulation of the proliferation of a mouse placenta-derived cell line by CSF-1 (12) suggest another function for uterine CSF-1. In this paper we describe the timing and sites of expression of CSF-1 and CSF-lR in the uterus and placenta throughout pregnancy. The data presented are compatible with a role for uterine CSF-1 in regulating both macrophage accumulation and the formation and differentiation of the placenta.
MATERIALS AND METHODS
Animals and Cells. Adult female Schneider or C57BL/6 mice were paired with males. Appearance of a vaginal plug was designated day 1 of pregnancy. Placental weights were determined after dissecting placenta free of fetal membranes and uterine tissue. The BAC1.2F5 cell line was grown as described (13) .
RNA Analysis. Paraffin sections of C57BL/6 mouse gravid uteri were subjected to in situ hybridization (14) by using [32P]CTP-labeled sense (control) or antisense (experimental) RNA probes transcribed from pGEM2-MCSF53 (15) and p755 (16) directed against mouse CSF-1 and mouse c-fms (CSF-1R), respectively. After autoradiography, slides were stained with hematoxylin/eosin prior to photographic or grain-count analysis.
Total RNA was isolated, and 20-,tg samples were electrophoresed on formaldehyde-agarose gels, blotted onto Hybond filters (Amersham), and hybridized as described (6) . Blots were reprobed with aXenopus rRNA probe (pXI1O1A), and the level of 18S rRNA was used for normalization of RNA loading and transfer. Slot-blot analysis was performed by loading serial dilutions of RNA onto nitrocellulose filters. RESULTS CSF-1 mRNA Expression. Fig. la (Fig. la) . The 4.6-kb mRNA species, although expressed at a lower level than the 2.3-kb form at all times during gestation, followed a similar time course of expression (Figs. la and 2A). Essentially an identical pattern was detected during gestation in C57BL/6 mice (data not shown). On day 15 of gestation, the expression of total CSF-1 mRNAs by slot-blot analysis, which detects a very low level of hybridization in control tissue, was at least 125-fold greater than that in the nonpregnant uterus (data not shown). CSF-1 mRNA could not be detected in placental samples by Northern blotting (data not shown).
To analyze the uterine expression of CSF-1 mRNA, in situ hybridization was performed during the pre-and postimplantation periods. CSF-1 mRNA expression was undetectable in nonpregnant uteri, but it increased steadily in uterine epithelium from day 2 after mating, with significantly elevated levels detected by day 3 of gestation ( Fig. 2B ). This increased expression coincided with the first production of progesterone (17) , and it was noticeable that on days 3-4 the epithelium displayed a morphology characteristic of progesterone exposure (18) , with regularly aligned nuclei, subnuclear vacuolation, and corrugated luminal cell surfaces. CSF-1 mRNA expression per cell then continued to increase through the period of implantation to reach a peak of expression between days 11 and 13 of gestation, followed by a decline on day 15 ( Fig. 2B ). CSF-1 mRNA at all stages of pregnancy was only detected in the luminal and glandular epithelium ( Fig. 3 a-d and Fig. 4b ). It was not confined to sites of implantation and could be detected at similar levels in both the luminal and glandular epithelium in uterine areas well away from conceptuses (data not shown). However, prior to implantation, CSF-1 mRNA levels were consistently higher in the luminal than in the glandular epithelia (data not shown). Interestingly, when the epithelium converted from a typically columnar to a squamous epithelium (often close to the placenta), CSF-1 mRNA expression was lost ( Fig. 3 c and d ). 7 and 8 are those determined for the implantation site. In B, the grains per cell are the average number of grains per cell in the sections probed with an antisense CSF-1 cRNA probe minus the number obtained in a section from the equivalent day of pregnancy probed with the sense-strand probe. At least 750 grains were counted in every section. In the nonpregnant animal, the value with the antisense probe was -0.14 grains per cell. Significant increases were considered to be >0.28 grains per cell.
CSF-1R mRNA Expression. An approximately 4.5-kb CSF-1R mRNA was detected in placenta (Fig. lb) . This mRNA size was comparable to that reported in macrophages (16) and was similar to that detected in the mouse macrophage cell line BAC1.2F5 (Fig. lb) . There was high CSF-lR mRNA expression in the placenta throughout pregnancy until day 17, when the-concentration decreased. There was no statistically significant difference in-the concentration between days 9 and 15. The changing pattern of cell types in the placenta may explain why levels were somewhat variable between animals. After day 17, in at least four different animals, expression was always lower than that during days 9 to 16. The more marked variation on days 16 and 17 ( Fig. lb) is probably due to slightly different durations of gestation between individual mice. Fig. 2C shows that the placenta grew rapidly from day 9, the first day it could be removed substantially free of uterine contamination, through day 15, when it attained a constant weight until term. Northern blots also showed expression of CSF-lR mRNA in uterine RNA from day 6 of pregnancy onwards (Fig. lb) . A significant enrichment of this mRNA was found in samples derived from areas of implantation (3 times higher on day 7) than from the interimplantation areas (Fig. lb) .
To determine which cells express CSF-lR mRNA and to determine the pattern of expression in the placenta, in situ hybridization was performed on gravid uteri at different days of pregnancy. On day 7.5, high levels of CSF-1R mRNA expression were detected in maternal decidua (Fig. 3 e andf) . This hybridization was highest in the region immediately around the implanting blastocyst and declined towards the outer decidual zone. By day 9.5 of pregnancy, expression of CSF-1R mRNA was detected in the decidua basalis (Fig. 5b) , but by the time the mature placenta was formed (day 11 onwards), little if any expression could be found in either the decidua capularis or basalis (Fig. 3 g and h; data not shown) as it became compressed and fibrotic (19) . Significant expression of CSF-1R mRNA was also found on the invading trophoblasts at day 7.5, although at the resolution of the the giant cells of the trophectoderm). Once the differentiated placental elements could be identified, however, the major expression of the CSF-1R mRNA was in giant trophoblasts. This high level of expression continued on these giant cells until term (Fig. 3 g and h, Fig. 4 a and c, Fig. 5 a-d and data not shown). No differences could be detected between mural and polar giant trophoblasts (Fig. 5 b and d) . In some cases in both the developing and mature placenta, the epithelial cells producing CSF-1 abutted against the giant trophoblasts expressing CSF-1R mRNA (Fig. 3 c, d , g and h and Fig. 4 a and b).
CSF-1R mRNA expression could also be shown in diploid trophoblasts during the formation of the placenta, when the spongiotrophoblastic and labyrinthine layers had not yet become established (Fig. 5 a and b) . In mature placenta, when the different cell layers could be easily identified, CSF-1R mRNA expression was found at high levels throughout the spongiotrophoblastic layer and also at lower levels in the labyrinthine region (Fig. 3 g and h) . At late stages of gestation, the relative increase in the proportion of the labyrinthine layer (19) with its lower level of CSF-1R mRNA probably accounts for the decline in CSF-1R mRNA levels detected on Northern blots. Significant but low levels of CSF-1R mRNA expression were also found in the visceral yolk sac on day 11 (Fig. 4 c and d) as well as in occasional mononuclear cells, particularly in the fetal liver (data not shown), although a systematic study was not performed on the fetus. No expression could be detected in the allantois or amnion. This expression pattern in the placenta with expression on the giant cell layer > spongiotrophoblastic layer > labyrinthine layer and in the extraembryonic membranes, once established, persisted throughout gestation.
DISCUSSION
Increased concentrations of uterine CSF-1 over nonpregnant uteri are detected within 5 days of copulation, and its concentration continues to increase dramatically through gestation (5) . CSF-1 is also found in placenta, amniotic fluid, and at low concentrations in the fetus (5, 20, 21) . CSF-1 mRNA is restricted to the luminal and glandular epithelium throughout pregnancy, indicating that the CSF-1 detected in the placenta and amniotic fluid is synthesized in the uterus.
During pregnancy, until day 16, there is a close parallel between CSF-1 mRNA levels detected by Northern blotting and the uterine accumulation ofCSF-1. After day 16, both the CSF-1 mRNA and CSF-1R mRNA levels decline, but CSF-1 continues to accumulate. These data suggest that, although production of CSF-1 is reduced, destruction via the CSF-1R (22) is even more reduced, resulting in a steady increase in the uterine CSF-1 concentration. The peak of uterine CSF-1 mRNA per cell detected by in situ hybridization is observed on day 13, whereas the peak of uterine CSF-1 mRNA detected by Northern blotting is on day 15. The most obvious explanation for this difference is that there is an increase in the proportion of uterine columnar epithelial cells in the uterus at this time.
The increased uterine CSF-1 concentrations found in the first half of pregnancy can be mimicked by treatment of ovariectomized mice with progesterone, estradiol-1713, and a decidual stimulus and was associated with an elevation in uterine CSF-1 mRNA (6). Consistent with these observations, by day 3 of pregnancy, when the luminal and glandular epithelium first appeared progestational, significantly increased epithelial CSF-1 mRNA levels could be detected by in situ hybridization. During pregnancy, the increase in epithelial CSF-1 mRNA level was not confined to the sites of implantation or at later times to the areas of the conceptus. Together these observations strongly suggest that uterine CSF-1 synthesis during gestation is under systemic control involving ovarian sex steroids.
The cell types expressing CSF-1R mRNA change during pregnancy. Initially, during decidualization, there is expression by maternal decidual cells, particularly those in the periimplantation region. These cells are unlikely to be macrophages, which are known to accumulate in the uterus during pregnancy (7), because the cells expressing CSF-1R mRNA are not macrophage-like. However, the possibility that some of the cells detected in the decidual layer are macrophages cannot be excluded. Invading trophoectodermal cells on day 7.5 also express CSF-1R mRNA but at a lower level than decidual cells. Transformation of the trophoblasts into giant trophoblasts is associated with a dramatic enhancement of CSF-1R mRNA expression, independent of their location around the conceptus. Diploid spongiotrophoblasts also express CSF-1R mRNA, and when the definitive layers of the placenta are formed, a lower level of expression can also be detected in the labyrinthine layer. Visceral yolk sac cells and macrophages also express CSF-1R mRNA. Previous studies have shown that yolk sacconditioned medium contains CSF-1 (23) . The role of uterine CSF-1 in the regulation of yolk sac cells is not clear.
During the preparation of this manuscript, Regenstreif and Rossant (24) communicated to us their then unpublished results of a similar qualitative in situ hybridization study. Their data describing the localization of the CSF-1 and CSF-1R mRNAs agree with those reported here. However, we have detected CSF-1 and CSF-1R mRNA at earlier stages than they reported and have been able to quantitate the Developmental Biology: Arceci et al.
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changing levels of these mRNAs. While CSF-1 mRNA has been detected in placental samples by Northern blotting (6, 20) , both in situ studies failed to detect significant placental CSF-1 mRNA. This suggests that the detection of "placental" CSF-1 mRNA by Northern blotting was due to uterine contamination of placental samples.
CSF-1 has been shown to be a chemoattractant for macrophages (25) ; thus, uterine CSF-1 may have a role in uterine macrophage recruitment and/or proliferation. Uterine macrophages immunosuppress the host response to the semiallogenic fetus (26) and produce a variety of cytokines (27) . These cytokines may act directly on cells of the uteroplacental unit (27, 28) or be involved in regulatory networks (12, 28) with other blood cells localized at the uteroplacental interface. Although CSF-1 does not activate macrophages in a classical sense (reviewed in ref. 29) , such an immunological role for uterine CSF-1 cannot be ruled out.
The expression of uterine CSF-1 mRNA and trophoblastic CSF-1R mRNA is correlated with the period of maximal proliferation of trophoblasts and placental growth (19) , consistent with the regulation of trophoblast growth and development by uterine CSF-1. The CSF-1-stimulated proliferation of primary mouse placental cells and mouse placental cell lines (12) provides further evidence supporting this regulatory role for CSF-1. Very high levels of CSF-1R mRNA expression were also detected in trophoblastic giant cells, which are unable to proliferate but endoreduplicate DNA (30) . Interestingly, maternal decidual cells, which also express CSF-1R mRNA, similarly undergo polyploidization (31). Therefore, it is possible that endoreduplication of DNA in these two different cell types is regulated by CSF-1. However, CSF-1 probably has roles other than the stimulation of trophoblast DNA synthesis and cell proliferation because CSF-1 and CSF-1R mRNA expression could still be detected in the placenta after it had ceased to grow. In this context, it is relevant to note that CSF-1 regulates the survival and differentiation of mononuclear phagocytes as well as their proliferation (4) . The diverse endocrine functions of giant trophoblasts (32) may also be regulated by CSF-1, which stimulates macrophages to produce several biologically active compounds including cytokines (33) . From a mechanistic standpoint, it is also interesting that CSF-1 can be expressed in both secreted and cell surface forms (34) . If blastocysts express the CSF-1R in the trophectoderm prior to implantation, cell-to-cell interaction may play a role in ovoreceptivity or trophectoderm invasion once the blastocyst is correctly positioned at the antimesometrial uterine lunimal epithelial surface. Similarly, the later apposition between uterine epithelial cells and trophoblast giant cells could also involve a CSF-1/CSF-1R-mediated cellto-cell interaction. The diversity of the CSF-1 functions in the uterus and placenta and the mechanisms of its actions remain to be elucidated.
